G Ford, N Freemantle. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseCerebrovascular Disorders/drug therapyEuropeFibrinolytic Agents/therapeutic useHumansTime FactorsTissue Plasminogen Activator/therapeutic useTreatment Outcome
Substances: See more » Fibrinolytic AgentsTissue Plasminogen Activator
Year: 1999 PMID: 10023968 DOI: 10.1016/s0140-6736(98)00005-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321